Date Wed, 10/09/2024 - 12:00 Media Pharmacy October 2024 Edit Implementation Schedule through February 2025 Sickle Cell Disease Annual Report October 2024 Sickle Cell Disease Proposal October 2024 Gene Therapies for Sickle Cell Disease and Beta-Thalassemia Proposal October 2024 Bile Salt Proposal October 2024 Iqirvo (elafibranor) NDFB October 2024 Complement Inhibitors Systemic Proposal October 2024 Voydeya (danicopan) NDFB October 2024 Duchenne Muscular Dystrophy Proposal October 2024 Elevidys (delandistrogene moxeparvovec-rokl) NDFB October 2024 Epidermolysis Bullosa Proposal October 2024 Filsuvez (birch triterpenes) NDFB October 2024 Hemophilia Gene Therapy Agents Proposal October 2024 Beqvez (fidanacogene elaparvovec-dzkt) NDFB October 2024 Winrevair Proposal October 2024 Winrevair (sotatercept-csrk) NDFB October 2024 Xolremdi Proposal October 2024 Xolremdi (mavorixafor) NDFB October 2024 Agenda RDAC Agenda October 2024 Minutes RDAC Minutes October 2024 Approved Criteria Page Rare Disease Council Meeting Information